{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:11:48Z","timestamp":1789668708245,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005747","name":"AP M\u00f8ller Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008249","name":"Frimodt Henike Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010983","name":"Health Research Foundation of Central Denmark Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010983","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003035","name":"Aase and Ejnar Danielsens Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.semarthrit.2026.152982","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:39:07Z","timestamp":1776353947000},"page":"152982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Patient-reported outcome measures in incident Polymyalgia Rheumatica: Changes after treatment initiation, short-term glucocorticoid discontinuation, and at one-year follow-up"],"prefix":"10.1016","volume":"78","author":[{"given":"Asger Buch","family":"Bjerre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas Wiggers","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffer S\u00f8vs\u00f8","family":"V\u00e5ben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ib T\u00f8nder","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren Geill","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Blegvad-Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit Dalsgaard","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M\u00f8ller","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen-Margrethe","family":"Hauge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kresten Krarup","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.semarthrit.2026.152982_bib0001","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/joim.13525","article-title":"An update on polymyalgia rheumatica","volume":"292","author":"Lundberg","year":"2022","journal-title":"J Intern Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152982_bib0002","first-page":"748","article-title":"Adrenal gland hypofunction in active polymyalgia rheumatica. Effect of glucocorticoid treatment on adrenal hormones and interleukin 6","volume":"29","author":"Cutolo","year":"2002","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.152982_bib0003","first-page":"1219","article-title":"Further evidence for insufficient hypothalamic-pituitary-glandular axes in polymyalgia rheumatica","volume":"33","author":"Straub","year":"2006","journal-title":"J Rheumatol"},{"issue":"5 Suppl 68","key":"10.1016\/j.semarthrit.2026.152982_bib0004","first-page":"S143","article-title":"Glucocorticoid treatment of polymyalgia rheumatica","volume":"29","author":"Caporali","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152982_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10067-021-05819-z","article-title":"Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis","volume":"41","author":"Floris","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.152982_bib0006","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s10067-026-07965-8","article-title":"Frailty phenotypes and determinants of glucocorticoid-related adverse events in polymyalgia rheumatica at 12 months: a real-life single-center investigation","volume":"45","author":"Hysa","year":"2026","journal-title":"Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.152982_bib0007","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrrheum.2015.116","article-title":"Patient-reported outcomes in core domain sets for rheumatic diseases","volume":"11","author":"van Tuyl","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.152982_bib0008","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3899\/jrheum.161109","article-title":"The OMERACT core domain set for outcome measures for clinical trials in polymyalgia rheumatica","volume":"44","author":"Mackie","year":"2017","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.152982_bib0009","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3899\/jrheum.181050","article-title":"Toward a core outcome measurement set for Polymyalgia Rheumatica: report from the OMERACT 2018 special interest group","volume":"46","author":"Owen","year":"2019","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.152982_bib0010","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3899\/jrheum.190575","article-title":"Feasibility and face validity of outcome measures for use in future studies of polymyalgia Rheumatica: an OMERACT study","volume":"47","author":"Yates","year":"2020","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152982_bib0011","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.rdc.2016.01.012","article-title":"The history of patient-reported outcomes in rheumatology","volume":"42","author":"Callahan","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152982_bib0012","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/rheumatology\/keac317","article-title":"Development and psychometric evaluation of the PMR-Impact Scale: a new patient reported outcome measure for polymyalgia rheumatica","volume":"62","author":"Twohig","year":"2023","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.152982_bib0013","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00296-015-3416-9","article-title":"Patient-reported outcomes in trials of patients with polymyalgia rheumatica: a systematic literature review","volume":"36","author":"Huang","year":"2016","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.152982_bib0014","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5114\/reum.2021.106221","article-title":"Not just pain and morning stiffness duration in the daily experience of patients with polymyalgia rheumatica. Does the rheumatologist listen to all patient-reported outcomes?","volume":"59","author":"Manzo","year":"2021","journal-title":"Reumatologia"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.152982_bib0015","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/ard.2003.011379","article-title":"A disease activity score for polymyalgia rheumatica","volume":"63","author":"Leeb","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152982_bib0016","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3899\/jrheum.110977","article-title":"Patient-reported outcomes in polymyalgia rheumatica","volume":"39","author":"Matteson","year":"2012","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.152982_bib0017","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/39.8.883","article-title":"A study of the health assessment questionnaire to evaluate functional status in polymyalgia rheumatica","volume":"39","author":"Kalke","year":"2000","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152982_bib0018","first-page":"151","article-title":"Symptom severity and glucocorticoid dosing in patients with polymyalgia rheumatica and obesity","volume":"52","author":"Cimmino","year":"2025","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.152982_bib0019","article-title":"The relationship between obesity and patient-reported outcome measures in people with polymyalgia rheumatica","volume":"8","author":"Scott","year":"2024","journal-title":"Rheumatol Adv Pr"},{"key":"10.1016\/j.semarthrit.2026.152982_bib0020","doi-asserted-by":"crossref","DOI":"10.1097\/RHU.0000000000002219","article-title":"Higher rates of depression in polymyalgia rheumatica are strongly associated with poor physical function","author":"Leung","year":"2025","journal-title":"J Clin Rheumatol"},{"issue":"Suppl 9","key":"10.1016\/j.semarthrit.2026.152982_bib0021","article-title":"Role of patient reported outcomes in predicting disease relapse at one year in those with polymyalgia Rheumatica [abstract]","volume":"76","author":"Harkins","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152982_bib0022","doi-asserted-by":"crossref","first-page":"100","DOI":"10.7812\/TPP\/23.022","article-title":"Benefits and challenges of remote patient monitoring as perceived by health care practitioners: a systematic review","volume":"27","author":"Serrano","year":"2023","journal-title":"Perm J"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.152982_bib0023","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s00259-024-06697-8","article-title":"The effect of prednisolone and a short-term prednisolone discontinuation for the diagnostic accuracy of FDG-PET\/CT in polymyalgia rheumatica-a prospective study of 101 patients","volume":"51","author":"Nielsen","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.152982_bib0024","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"2015 Recommendations for the management of polymyalgia rheumatica: a European league against rheumatism\/American college of rheumatology collaborative initiative","volume":"74","author":"Dejaco","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.152982_bib0025","series-title":"SF-36 physical and mental health summary scales.a user\u2019s manual","author":"Ware","year":"1994"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152982_bib0026","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152982_bib0027","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients: appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152982_bib0028","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1093\/rheumatology\/keae463","article-title":"Low incidence of late-onset giant cell arteritis during the first year in patients with polymyalgia rheumatica-a repeated imaging study","volume":"64","author":"Nielsen","year":"2025","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152982_bib0029","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s11136-017-1684-4","article-title":"Norwegian reference values for the short-form health survey 36: development over time","volume":"27","author":"Jacobsen","year":"2018","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152982_bib0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s41687-021-00331-z","article-title":"The Swedish RAND-36: psychometric characteristics and reference data from the Mid-Swed Health Survey","volume":"5","author":"Ohlsson-Nevo","year":"2021","journal-title":"J Patient Rep Outcomes"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152982_bib0031","article-title":"Long-term use of glucocorticoids for polymyalgia rheumatica: follow-up of the PMR cohort study","volume":"6","author":"Muller","year":"2022","journal-title":"Rheumatol Adv Pr"},{"key":"10.1016\/j.semarthrit.2026.152982_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1146815","article-title":"Patient-reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritis","volume":"10","author":"Froehlich","year":"2023","journal-title":"Front Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.152982_bib0033","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/acr.23280","article-title":"Tele-health followup strategy for tight control of disease activity in rheumatoid arthritis: results of a randomized controlled trial","volume":"70","author":"de Thurah","year":"2018","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152982_bib0034","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10067-013-2390-4","article-title":"Assessment of global disease activity in RA patients monitored in the METEOR database: the patient's versus the rheumatologist's opinion","volume":"33","author":"Gvozdenovi\u0107","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152982_bib0035","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/acr.20132","article-title":"Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis","volume":"62","author":"Barton","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152982_bib0036","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semarthrit.2011.12.003","article-title":"Differences in the patient's and the physician's perspective of disease in psoriatic arthritis","volume":"42","author":"Dandorfer","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152982_bib0037","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/acr.22401","article-title":"Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients","volume":"67","author":"Eder","year":"2015","journal-title":"Arthritis Care Res"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.152982_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103423","article-title":"Residual pain in rheumatoid arthritis: is it a real problem?","volume":"22","author":"Sarzi-Puttini","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152982_bib0039","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s10067-017-3691-9","article-title":"How common is depression in patients with polymyalgia rheumatica?","volume":"37","author":"Vivekanantham","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152982_bib0040","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.2024-0980","article-title":"More than pain and stiffness: persistent fatigue and sleep disturbance in polymyalgia rheumatica","author":"Leung","year":"2025","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152982_bib0041","article-title":"Improved diagnostic accuracy for polymyalgia rheumatica using FDG-PET\/CT with clinical diagnosis or 2012 ACR\/EULAR classification criteria","author":"Nielsen","year":"2024","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152982_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2021.105185","article-title":"Fast track clinic for early diagnosis of polymyalgia rheumatica: impact on symptom duration and prednisolone initiation","volume":"88","author":"Fr\u00f8lund","year":"2021","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.semarthrit.2026.152982_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2025.152793","article-title":"Impact of a rapid access strategy on referral rates, diagnosis, and glucocorticoid initiation in suspected polymyalgia rheumatica","volume":"74","author":"Nielsen","year":"2025","journal-title":"Semin Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226000715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226000715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:56:07Z","timestamp":1789667767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017226000715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"alternative-id":["S0049017226000715"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.152982","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-reported outcome measures in incident Polymyalgia Rheumatica: Changes after treatment initiation, short-term glucocorticoid discontinuation, and at one-year follow-up","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.152982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152982"}}